Jan Engelmann

534 total citations
19 papers, 268 citations indexed

About

Jan Engelmann is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Jan Engelmann has authored 19 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Biological Psychiatry. Recurrent topics in Jan Engelmann's work include Treatment of Major Depression (10 papers), Tryptophan and brain disorders (5 papers) and Bipolar Disorder and Treatment (4 papers). Jan Engelmann is often cited by papers focused on Treatment of Major Depression (10 papers), Tryptophan and brain disorders (5 papers) and Bipolar Disorder and Treatment (4 papers). Jan Engelmann collaborates with scholars based in Germany, Austria and Switzerland. Jan Engelmann's co-authors include Klaus Lieb, Nadine Dreimüller, Stefanie Wagner, André Tadić, David P. Herzog, Marianne B. Müller, Daniel Wollschläger, Alice Engel, Harald Murck and Giulia Treccani and has published in prestigious journals such as Blood, Journal of Affective Disorders and Journal of Psychiatric Research.

In The Last Decade

Jan Engelmann

17 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Engelmann Germany 10 114 70 65 60 54 19 268
Petra Kalember Croatia 7 96 0.8× 54 0.8× 65 1.0× 46 0.8× 68 1.3× 11 248
Rocco de Filippis Italy 9 117 1.0× 55 0.8× 46 0.7× 142 2.4× 36 0.7× 30 327
Colleen Rollins United Kingdom 7 88 0.8× 47 0.7× 83 1.3× 58 1.0× 98 1.8× 9 303
Xiaoyin Ke China 11 112 1.0× 109 1.6× 51 0.8× 56 0.9× 96 1.8× 16 356
Agnese Marsano Italy 7 82 0.7× 80 1.1× 47 0.7× 66 1.1× 37 0.7× 10 294
Amy Shah United States 4 96 0.8× 79 1.1× 66 1.0× 89 1.5× 32 0.6× 7 240
Aisha S. Shariq Canada 5 58 0.5× 89 1.3× 73 1.1× 62 1.0× 83 1.5× 5 307
Naji C. Salloum United States 9 222 1.9× 111 1.6× 54 0.8× 64 1.1× 38 0.7× 11 315
Vibeke H. Dam Denmark 12 106 0.9× 62 0.9× 70 1.1× 39 0.7× 135 2.5× 36 320
Nariko Katayama Japan 6 88 0.8× 110 1.6× 47 0.7× 33 0.6× 99 1.8× 12 312

Countries citing papers authored by Jan Engelmann

Since Specialization
Citations

This map shows the geographic impact of Jan Engelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Engelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Engelmann more than expected).

Fields of papers citing papers by Jan Engelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Engelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Engelmann. The network helps show where Jan Engelmann may publish in the future.

Co-authorship network of co-authors of Jan Engelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Engelmann. A scholar is included among the top collaborators of Jan Engelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Engelmann. Jan Engelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Endres, Kristina, et al.. (2025). Emergence of graphene-based biosensors for improved treatment response prediction in major depressive disorder: a perspective. 2D Materials. 12(3). 33004–33004. 1 indexed citations
2.
Lieb, Klaus, Fabian Streit, Swapnil Awasthi, et al.. (2024). Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response. Journal of Affective Disorders. 363. 542–551. 3 indexed citations
3.
Engelmann, Jan, Lea Zillich, Josef Frank, et al.. (2022). Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial. Translational Psychiatry. 12(1). 268–268. 11 indexed citations
4.
Hiemke, Christoph, Andreas Conca, Jan Engelmann, et al.. (2022). Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range. Pharmacopsychiatry. 55(3). 164–165. 1 indexed citations
5.
Hiemke, Christoph, Andreas Conca, Jan Engelmann, et al.. (2022). Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy. Frontiers in Psychiatry. 13. 972141–972141. 15 indexed citations
6.
Engelmann, Jan, Harald Murck, Stefanie Wagner, et al.. (2022). Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder. The World Journal of Biological Psychiatry. 23(8). 631–642. 4 indexed citations
7.
Herzog, David P., Natarajan Perumal, Caroline Manicam, et al.. (2021). Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK). Neurobiology of Stress. 15. 100404–100404. 12 indexed citations
8.
Herzog, David P., Stefanie Wagner, Jan Engelmann, et al.. (2021). Early onset of depression and treatment outcome in patients with major depressive disorder. Journal of Psychiatric Research. 139. 150–158. 30 indexed citations
9.
Philipsen, Alexandra, et al.. (2021). Enantioselective Quantification of Amphetamine and Metabolites in Serum Samples: Forensic Evaluation and Estimation of Consumption Time. Metabolites. 11(8). 521–521. 12 indexed citations
10.
Krämer, Michael, Alexandra Philipsen, Nadine Dreimüller, et al.. (2021). Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study. Drug Testing and Analysis. 13(9). 1614–1626. 8 indexed citations
11.
Engelmann, Jan, Stefanie Wagner, David P. Herzog, et al.. (2020). Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 41(1). 62–66. 8 indexed citations
12.
Wagner, Stefanie, Daniel Wollschläger, Nadine Dreimüller, et al.. (2020). Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years. Comprehensive Psychiatry. 99. 152170–152170. 23 indexed citations
13.
Engelmann, Jan, Stefanie Wagner, Daniel Wollschläger, et al.. (2019). Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment. European Archives of Psychiatry and Clinical Neuroscience. 270(2). 183–193. 11 indexed citations
14.
Dreimüller, Nadine, Klaus Lieb, André Tadić, et al.. (2019). Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response. Journal of Affective Disorders. 256. 524–531. 43 indexed citations
15.
Wagner, Stefanie, Sarah Kayser, Jan Engelmann, et al.. (2018). Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder. The World Journal of Biological Psychiatry. 20(7). 519–530. 20 indexed citations
16.
Engelmann, Jan, Stefanie Wagner, & Sarah Kayser. (2018). Update Elektrokonvulsionstherapie — klinische Anwendung. InFo Neurologie + Psychiatrie. 20(1). 40–48.
17.
Wagner, Stefanie, André Tadić, Alice Engel, et al.. (2017). A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders. Journal of Affective Disorders. 221. 184–191. 7 indexed citations
18.
Wagner, Stefanie, Alice Engel, Jan Engelmann, et al.. (2017). Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis. Journal of Psychiatric Research. 94. 96–106. 59 indexed citations
19.
Schlenk, Richard F., Karina Eiwen, Jan Engelmann, et al.. (2011). Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias. Blood. 118(21). 1441–1441.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Kalember Breakdown of academic impact, for papers by Rocco de Filippis Breakdown of academic impact, for papers by Colleen Rollins Breakdown of academic impact, for papers by Xiaoyin Ke Breakdown of academic impact, for papers by Agnese Marsano Breakdown of academic impact, for papers by Amy Shah Breakdown of academic impact, for papers by Aisha S. Shariq Breakdown of academic impact, for papers by Naji C. Salloum Breakdown of academic impact, for papers by Vibeke H. Dam Breakdown of academic impact, for papers by Nariko Katayama
Rankless by CCL
2026